Discover open access scientific publications

Search, annotate, share and cite publications

Publications by G. Rake

MA09.03 Multiple Pathological Variables Predict Efficacy of Adjuvant Chemotherapy in Primary Lung Adenocarcinoma

Journal of Thoracic Oncology

English

Related publications

MA05.03 Immune Microenvironment and Its Association With Adjuvant Chemotherapy Benefit in Locoregionally Advanced Lung Adenocarcinoma

Journal of Thoracic Oncology

English

TRAP1 Is a Predictive Biomarker of Platinum-Based Adjuvant Chemotherapy Benefits in Patients With Resected Lung Adenocarcinoma

English

Can Shear Wave Elastography Variables Predict the Pathological Response to Neoadjuvant Chemotherapy in Patients With Invasive Breast Cancer?

Ultrasound in Medicine and Biology

Ultrasonics

Radiology

Ultrasound Technology

English

Epidermal Growth Factor Receptor Mutation Status and Adjuvant Chemotherapy With Uracil-Tegafur for Adenocarcinoma of the Lung

Journal of Clinical Oncology

English

Multidrug Resistance Proteins Do Not Predict Benefit of Adjuvant Chemotherapy in Patients With Completely Resected Non-Small Cell Lung Cancer: International Adjuvant Lung Cancer Trial Biologic Program

Clinical Cancer Research

Cancer Research

Oncology

2007

English

Adjuvant Chemotherapy Following Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma – Factors Affecting Receipt and Completion of Chemotherapy

English

Safety of Adjuvant Chemotherapy With Carboplatin and Weekly Paclitaxel for Pathological Stage IB-IIIB Non-Small Cell Lung Cancer

Japanese Journal of Lung Cancer

English

P2.16-49 Which Nomogram Is More Reliable to Predict Recurrence of Pathological Stage IA Lung Adenocarcinoma Treated by Surgery?

Journal of Thoracic Oncology

English

Multiple Primary Lung Cancers Containing Adenocarcinoma With EGFR Gene Mutation and Adenocarcinoma With Strong PD-L1 Positivity

Japanese Journal of Lung Cancer

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by G. Rake

MA09.03 Multiple Pathological Variables Predict Efficacy of Adjuvant Chemotherapy in Primary Lung Adenocarcinoma

Related publications

MA05.03 Immune Microenvironment and Its Association With Adjuvant Chemotherapy Benefit in Locoregionally Advanced Lung Adenocarcinoma

TRAP1 Is a Predictive Biomarker of Platinum-Based Adjuvant Chemotherapy Benefits in Patients With Resected Lung Adenocarcinoma

Can Shear Wave Elastography Variables Predict the Pathological Response to Neoadjuvant Chemotherapy in Patients With Invasive Breast Cancer?

Epidermal Growth Factor Receptor Mutation Status and Adjuvant Chemotherapy With Uracil-Tegafur for Adenocarcinoma of the Lung

Multidrug Resistance Proteins Do Not Predict Benefit of Adjuvant Chemotherapy in Patients With Completely Resected Non-Small Cell Lung Cancer: International Adjuvant Lung Cancer Trial Biologic Program

Adjuvant Chemotherapy Following Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma – Factors Affecting Receipt and Completion of Chemotherapy

Safety of Adjuvant Chemotherapy With Carboplatin and Weekly Paclitaxel for Pathological Stage IB-IIIB Non-Small Cell Lung Cancer

P2.16-49 Which Nomogram Is More Reliable to Predict Recurrence of Pathological Stage IA Lung Adenocarcinoma Treated by Surgery?

Multiple Primary Lung Cancers Containing Adenocarcinoma With EGFR Gene Mutation and Adenocarcinoma With Strong PD-L1 Positivity